HitmAb
"HitmAb" is a trademark owned by Zhuhai Trinomab Pharmaceutical Co., Ltd., filed at the WIPO on April 26, 2021. It is registered and covers classes 5, 35 and 42.
- Status
- Registered
- Filed
- April 26, 2021
- Registered
- Not yet
- Expires
- April 26, 2031
- Application no.
- Not recorded
- Registration no.
- 1603221
- Office
- WIPO
- World Intellectual Property Organization
- Mark type
- Trademark
- 3 classes
Who owns HitmAb
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Zhuhai Trinomab Pharmaceutical Co., Ltd.
China
Representative
Scot A. Duvall
Middleton Reutlinger
What the mark covers
The products and services HitmAb is filed for, grouped by Nice class.
Vaccines; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; pharmaceutical preparations; drugs for medical purposes; biological preparations for medical purposes; medicines for human purposes; chemico-pharmaceutical preparations; chemical preparations for pharmaceutical purposes.
Retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies.
Biological research; research and development of new products for others; scientific laboratory services; scientific research; chemical analysis; clinical trials; technological research; conducting technical project studies; chemistry services; chemical research.
About HitmAb
Who owns the trademark "HitmAb"?
The WIPO trademark "HitmAb" is owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
What is the status of "HitmAb"?
Its status at the WIPO is: registered.
Get this data via the API
Everything on this page comes from the Signa API. Pull HitmAb and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_9379d180-e5de-466f-adea-c7e5163a50f4
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_9379d180-e5de-466f-adea-c7e5163a50f4",
"object": "trademark",
"mark_text": "HitmAb",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "WO",
"application_number": null,
"filing_date": "2021-04-26",
"nice_classes": [
5,
35,
42
],
"owners": [
{
"name": "Zhuhai Trinomab Pharmaceutical Co., Ltd.",
"entity_id": "ent_019ebb64-8b23-733c-9a8b-efcae9acbffe"
}
]
}